专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

131. 发明公开

KR1020110107339A 생강 및 에키나세아 안구스티폴리아의 친유성 추출물을 포함하는 위-식도 역류 및 화학요법으로 유발된 구토의 예방 및 치료용 조성물 有权
标题翻译：包含ZINGIBER OFFICINALE和ECHINACEA ANGUSTIFOLIA的LIPOPHILIC提取物的组合物用于预防和治疗胃肠外反射和化疗诱发的EMESIS
公开(公告)号：KR1020110107339A
公开(公告)日：2011-09-30
申请号：KR1020117016829
申请日：2010-01-15
申请人： 인데나 에스.피.에이
发明人： 봄바르델리에지오
IPC分类号： A61K36/9068 , A61K36/28 , A61K9/00 , A61K9/48
CPC分类号： A61K36/9068 , A61K36/28 , A61K9/0053 , A61K9/4825 , A61K2236/37
摘要： 본 발명은 식도 역류 및 화학요법에 의해 유발된 구토의 예방 및 치료에 유용한, 초임계 조건하에서 이산화탄소를 사용한 추출에 의해 수득된 생강(
Zingiber
officinale ) 및 에키나세아 안구스티폴리아(
Echinacea angustifolia )의 친유성 추출물의 조합을 포함하는 조성물에 관한 것이다.

132. 发明公开

KR1020100015799A 차폐 또는 코팅된 구리염의 황반 변성의 치료를 위한 용도 有权
标题翻译：使用掩蔽或涂覆的铜盐处理玉米变质
公开(公告)号：KR1020100015799A
公开(公告)日：2010-02-12
申请号：KR1020097022078
申请日：2008-03-19
申请人： 노파르티스 아게
发明人： 키스,게오르크루드비히 , 반데르만데,자크
IPC分类号： A61K33/34 , A61P27/02 , A61K9/48
CPC分类号： A61K33/34 , A23L33/105 , A23L33/12 , A23L33/15 , A23L33/16 , A23P20/10 , A61K9/4825 , A61K31/30 , A61K31/355 , A61K31/375 , A61K47/6951 , B82Y5/00 , A61K2300/00
摘要： The present invention relates to a method of protecting copper-sensitive compounds and/or compositions from decomposition, by using a masked or coated copper salt. Preferably, the cooper is coated with gelatine, a liposome, or a mono-and di-glyceride.
摘要翻译：本发明涉及通过使用掩蔽或涂覆的铜盐来保护铜敏感化合物和/或组合物免于分解的方法。优选地，铜包被明胶，脂质体或单甘油酯和二甘油酯。

133. 发明公开

KR1020090109130A 캡슐화된 피코플라틴 无效
标题翻译：封闭的PICPLATIN
公开(公告)号：KR1020090109130A
公开(公告)日：2009-10-19
申请号：KR1020097018781
申请日：2008-02-08
申请人： 포니아드 파마슈티칼즈, 인크.
发明人： 레이,알리스테어제이. , 프로키신,크리스토퍼에이. , 필립스,엔젤리카 , 브라이츠,헤이젤비.
IPC分类号： A61K9/48 , A61K33/28 , A61P35/00 , A61K47/26
CPC分类号： A61K9/4816 , A61K9/1652 , A61K9/4825 , A61K9/4833 , A61K9/4858 , A61K9/4866 , A61K31/28 , A61K31/44 , A61K31/555 , A61K33/24
摘要： The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt% picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt% of a lubricant.
摘要翻译：本发明提供了一种用于吡铂的胶囊化单位剂量形式，其适于口服给药皮质素，其含有基本上干燥的粉末，其具有皮质颗粒物理形式的约20至55重量％的吡铂，其中平均吡铂粒径小于约 10微米。皮普铂颗粒分散在制剂的粉末中，其包括基本上水溶性的水分散性或吸水性碳水化合物和有效量的至多约5重量％的润滑剂。

134. 发明公开

KR1020090024248A ＣＸＣＲ2의 선택적 길항제 또는 ＣＸＣＲ1과 ＣＸＣＲ2 둘다의 선택적 길항제의 약제학적 제형 및 조성물, 및 염증성 질환을 치료하기 위한 이의 사용방법 无效
标题翻译： CXCR2或CXCR1和CXCR2的选择性拮抗剂的药物制剂和组合物及其使用方法治疗炎症性疾病
公开(公告)号：KR1020090024248A
公开(公告)日：2009-03-06
申请号：KR1020097000469
申请日：2007-06-12
申请人： 머크 샤프 앤드 돔 코포레이션
发明人： 코우짐에이치. , 에이크만조나단디.
IPC分类号： A61K47/20 , A61P29/00 , A61K47/26
CPC分类号： A61K9/4825 , A61K9/1623 , A61K9/1635 , A61K9/1652 , A61K9/4808 , A61K9/4858 , A61K9/4866 , A61K47/10 , A61K47/20 , A61K47/26 , A61K47/32 , A61K47/38
摘要： The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful for treating inflammatory disorders.
摘要翻译：本发明提供了组合物以及基于可用于治疗炎症性疾病的CXCR2或CXCR1和CXCR2两者的选择性拮抗剂的试剂盒和方法。

135. 发明公开

KR1020070041675A 젤라틴 피막용 조성물, 젤라틴 피막, 및 이를 이용한 캡슐제 有权
标题翻译：胶囊，胶囊和胶囊的组合物
公开(公告)号：KR1020070041675A
公开(公告)日：2007-04-19
申请号：KR1020067021951
申请日：2005-07-29
申请人： 와쿠나가 세이야쿠 가부시키 가이샤
发明人： 시모카와,요시유키 , 시라이시,스미히로 , 미하라,미카
IPC分类号： A61K9/56 , A61K47/24 , A61K31/661 , A61K31/19
CPC分类号： A61K9/4825 , A61K9/2873
摘要： 본 발명은, 젤라틴 피막의 경시적인 용해성 저하를 보다 고도로 억제하고, 특히 연 캡슐제의 경우, 동시에 캡슐에 충분한 강도를 부여하는 캡슐 피막용 조성물, 및 이를 이용한 캡슐 피막 및 캡슐제를 제공한다. 상기 캡슐 피막용 조성물은, 젤라틴(A)와, 일반식 C
6 H
12
-n ·(H
2 PO
4 )
n (식 중, n은 1~6의 정수를 나타냄)으로 표현되는 이노시톨린산(B)를 포함하는 것을 특징으로 한다.
젤라틴, 이노시톨린산, 캡슐제, DHA

136. 发明公开

KR1020070011307A 오메가-3 다중 불포화 지방산을 포함하는 연질 젤라틴 캡슐 有权
标题翻译：含有OMEGA-3聚氧乙烯脂肪酸的软胶囊
公开(公告)号：KR1020070011307A
公开(公告)日：2007-01-24
申请号：KR1020067018700
申请日：2005-02-07
申请人： 틸로츠 파마 아게
发明人： 사체토,장-피에르 , 버프톤,롤리 , 부저,토마스
IPC分类号： A61K9/48
CPC分类号： A61K31/202 , A61K9/4825 , A61K9/4891 , A61K31/20 , A61K31/201 , A61K31/23
摘要： A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule chararcterised in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin exrracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life. ® KIPO & WIPO 2007
摘要翻译：包含游离酸形式的至少一种ω-3多不饱和脂肪酸或其药理学上可接受的衍生物的药物制剂包含在被称为“明胶胶囊”的软明胶胶囊中，因为胶囊包括通过包括酸预处理胶原资源。本发明相对于含有相同制剂但包含通过包含碱性预处理胶原源的提取方法引发的明胶的软明胶胶囊的一个优点在于本发明不会随时间而显着变硬，因此具有更长的保质期。 ®KIPO＆WIPO 2007

137. 发明公开

KR1020060105013A 부틸프탈라이드의 연질캡슐 및 그 제조방법 有权
标题翻译：丁二醇软胶囊及其制备方法
公开(公告)号：KR1020060105013A
公开(公告)日：2006-10-09
申请号：KR1020067011030
申请日：2004-12-03
申请人： 씨에스피씨 종콰이 팔마씨우티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 , 씨에스피씨 엔비피 파마슈티컬 컴퍼니 리미티드
发明人： 리,지안큉 , 바이,민 , 구오,웬민 , 첸,수루이 , 리우,리운 , 조우,구이롱
IPC分类号： A61K9/48 , A61K31/343
CPC分类号： A61K9/4825 , A61K9/4816 , A61K9/4875 , A61K31/34 , A61K31/365
摘要： The present invention discloses a novel dosage form of butylphthalide soft capsule and its preparation procedure. Butylphthalide soft capsule is composed of a coating material and a drug-containing oil. The drug- containing oil is basically composed of butylphthalide and diluent - vegetable oil, wherein the weight ratio of butylphthalide to oil ranges from 1:0~10. The coating material is composed of gelatin, plasticizer and water, wherein the weight ratio of gelatin to plasticizer to water is in the range of 1:0.2~0.4:0.8~0.3. The butylphthalide soft capsule described in this invention can mask the strong and specific flavour of butylphthalide, and overcome the difficulties associated with formulating oily active agents into other oral preparations. The disintegration time of the soft capsule complies with the requirement of Pharmacopoeia of P.R. China.
摘要翻译：本发明公开了一种丁基苯酞软胶囊的新型剂型及其制备方法。丁苯酞软胶囊由涂料和含药油组成。含药油基本上由丁基苯酞和稀释剂 - 植物油组成，其中丁苯酞与油的重量比为1:0〜10。涂料由明胶，增塑剂和水组成，其中明胶与增塑剂与水的重量比在1:0.2〜0.4:0.8〜0.3的范围内。本发明中描述的丁基苯酞软胶囊可以掩蔽丁苯酞的强烈和特异的风味，并克服与将油性活性剂配制成其它口服制剂相关的困难。软胶囊的分解时间符合中国药典的药典要求。

138. 发明公开

KR1020060093721A 레티노이드-함유 연질 젤라틴 캡슐을 위한 새로운 제형 有权
标题翻译：用于含有软胶囊的新配方
公开(公告)号：KR1020060093721A
公开(公告)日：2006-08-25
申请号：KR1020067007881
申请日：2004-10-28
申请人： 바실리어 파마슈티카 아게
发明人： 디칭거귄터 , 가브릴베른하르트 , 슈미트-호프만안느-오르텅스 , 베펠지프루츠
IPC分类号： A61K9/48 , A61K31/185 , A61K31/203
CPC分类号： A61K9/4825 , A61K9/4858 , A61K31/07 , A61K31/203 , A61K47/46
摘要： A new pharmaceutical formulation for retinoid-containing soft gelatin capsules is disclosed. The new formulation comprises a soft gelatin capsule filled with a fill mass comprising a retinoid as an active ingredient, a natural vegetable oil, a partially hydrogenated natural vegetable oil and medium chain triglycerides. Optionally, the new formulation also comprises a natural wax. In a particularly preferred embodiment, the soft gelatin capsule comprises pig gelatin in the capsule shell in combination with the above fill mass.
摘要翻译：公开了含类视黄醇的软明胶胶囊的新药物制剂。该新制剂包括填充有包含类视黄醇作为活性成分的填充物质的软明胶胶囊，天然植物油，部分氢化天然植物油和中链甘油三酯。任选地，新制剂还包含天然蜡。在特别优选的实施方案中，软明胶胶囊与胶囊壳中的猪明胶结合，并与上述填充物组合。

139. 发明公开

KR1020040104089A 기능성 캡슐 无效
标题翻译：功能性胶囊，其组成为凝胶，木霉菌，维生素，追踪矿物，浸泡剂和增塑剂
公开(公告)号：KR1020040104089A
公开(公告)日：2004-12-10
申请号：KR1020030035499
申请日：2003-06-03
申请人： 라은경
发明人： 라은경 , 라종덕
IPC分类号： A61K9/48
CPC分类号： A61K9/4825 , A23P10/30 , A23V2002/00 , A23V2250/51 , A23V2250/5432 , A23V2250/70 , A61K47/22 , A61K47/26 , A61K47/36
摘要： PURPOSE: Provided is a composition of the functional capsule which is composed of gelatin, mucopolysaccharides, vitamins, trace minerals, sweeteners, and plasticizers. The capsule is used for encapsulation of foods, food additives or food additives. CONSTITUTION: The composition of the gelatin capsule which is used for encapsulation of drugs, foods or food additives is characterized by being composed of gelatin, mucopolysaccharides, vitamins, trace minerals, sweeteners, and plasticizers. Therefore, the composition has anticancer effect of the mucopolysaccharides, nourishing effect of the trace minerals, and bioactivating effect of the vitamins.
摘要翻译：目的：提供由明胶，粘多糖，维生素，微量矿物质，甜味剂和增塑剂组成的功能性胶囊的组合物。胶囊用于食品，食品添加剂或食品添加剂的包封。构成：用于包封药物，食品或食品添加剂的明胶胶囊的组成特征在于由明胶，粘多糖，维生素，微量矿物质，甜味剂和增塑剂组成。因此，该组合物具有粘多糖的抗癌作用，微量矿物质的滋养作用和维生素的生物活化作用。

140. 发明公开

KR1020040071050A 투수성이 개선된 젤라틴 경질 캡슐 失效
标题翻译：具有改善含有硫酸盐脂肪酸的水性渗透性的凝胶硬化剂具有抑制胶囊材料的水渗透性的作用，其抑制水分增加填料中的填料并防止长时间填充材料的测定
公开(公告)号：KR1020040071050A
公开(公告)日：2004-08-11
申请号：KR1020030098041
申请日：2003-12-27
申请人： 다이이치 고교 세이야쿠 가부시키가이샤
发明人： 무라츠바키야스타카
IPC分类号： A61K9/48
CPC分类号： A61K9/4825 , A61K47/14
摘要： PURPOSE: A gelatin hard capsule containing sucrose fatty ester having an HLB of 2 to 8 in which 70% by weight of fatty acid is stearic acid is provided. It inhibits water permeability of capsule material whereby inhibiting the moisture increase of filler material within the capsule and preventing the deterioration of the filler material for a long period of time. CONSTITUTION: The gelatin hard capsule contains 0.01 to 2.0 parts by weight of sucrose fatty ester having an HLB of 2 to 8, if necessary, pigments, colorants or other additives, based on 100 parts by weight of the solid content of the capsule. In the capsule, 50% or more by weight of fatty acid(preferably 60% or more by weight, more preferably 70% or more by weight and most preferably 80% or more by weight) is stearic acid. For an example, gelatin is dissolved in water to give 27% gelatin solution, which is mixed with 70% by weight of stearic acid and 30% by weight of palmitic acid.
摘要翻译：目的：提供含有HLB为2〜8的蔗糖脂肪酸酯的明胶硬胶囊，其中70重量％的脂肪酸为硬脂酸。它抑制胶囊材料的透水性，从而抑制胶囊内的填料的水分增加，并长期防止填料的劣化。构成：基于100重量份胶囊的固体含量，明胶硬胶囊含有0.01至2.0重量份HLB为2至8的蔗糖脂肪酸酯（如果需要的话）颜料，着色剂或其它添加剂。在胶囊中，50重量％以上的脂肪酸（优选为60重量％以上，更优选为70重量％以上，最优选为80重量％以上）为硬脂酸。例如，将明胶溶于水中，得到27％的明胶溶液，其与70重量％的硬脂酸和30重量％的棕榈酸混合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式